← Back to NVS

Novartis AG Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2025Filed 17/07/2025Jun 2024Filed 17/07/2025Jun 2023Filed 18/07/2024Jun 2022Filed 18/07/2023Jun 2021Filed 19/07/2022Jun 2020Filed 21/07/2021Jun 2019Filed 21/07/2020Jun 2018Filed 18/07/2019
$14,054$12,512$11,437$12,781$12,956$11,347$11,764$11,359
$4,024$3,246$2,317$1,695$2,895$1,867$6,800$7,768
$2.06$1.59$1.11$0.77$1.28$0.81$2.91$3.31

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.